Detalhe da pesquisa
1.
Microplastics and Nanoplastics in Atheromas and Cardiovascular Events.
N Engl J Med
; 390(10): 900-910, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38446676
2.
GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes.
Cardiovasc Diabetol
; 23(1): 10, 2024 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38184582
3.
SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes.
BMC Med
; 21(1): 71, 2023 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36829203
4.
Repurposing SGLT-2 Inhibitors to Target Aging: Available Evidence and Molecular Mechanisms.
Int J Mol Sci
; 23(20)2022 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36293181
5.
Organ-specific biological clocks: Ageotyping for personalized anti-aging medicine.
Ageing Res Rev
; 96: 102253, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38447609
6.
Weight variability and diabetes complications.
Diabetes Res Clin Pract
; 199: 110646, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37001818
7.
SIRT3 mediates the effects of PCSK9 inhibitors on inflammation, autophagy, and oxidative stress in endothelial cells.
Theranostics
; 13(2): 531-542, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36632236
8.
The legacy effect of hyperglycemia and early use of SGLT-2 inhibitors: a cohort study with newly-diagnosed people with type 2 diabetes.
Lancet Reg Health Eur
; 31: 100666, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37547276
9.
Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque.
Atherosclerosis
; 378: 117180, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37422356